mRNA-lipid nanoparticle vaccines provide protection against lethal Nipah virus infection
Authors:
Open Access
- 19 December 2025
- journal article
- research article
- Published by Springer Nature in npj Vaccines
- Vol. 11 (1)
Abstract
Nipah virus (NiV) is a zoonotic pathogen that causes severe encephalitis and respiratory disease in humans and multiple mammalian species. However, no licensed vaccines or therapeutics are currently available against NiV infection. In this study, we developed three mRNA vaccine candidates using a lipid nanoparticle (LNP) delivery platform: mRNA-F-LNP, comprising mRNA encoding the fusion protein (F); mRNA-G-LNP, containing mRNA encoding the attachment glycoprotein (G); and mRNA-GF-LNP, in which mRNAs encoding both F and G proteins were co-encapsulated at a 1:1 molar ratio. All three mRNA-LNPs induced robust and sustained immune responses in both mice and Syrian hamsters. Sera from immunized Syrian hamster showed high levels of cross-neutralizing antibodies against both NiV-Malaysia (NiV-M) and NiV-Bangladesh (NiV-B) strains. Notably, all three mRNA-LNPs conferred complete protection against a lethal challenge with NiV-M in Syrian hamsters. These findings demonstrate that these mRNA-based vaccines are highly immunogenic and efficacious, highlighting their potential as promising candidates for NiV vaccine development.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFD1800500)
- National Key Research and Development Program of China (2022YFD1800500)
This publication has 46 references indexed in Scilit:
- Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspectiveJournal of Controlled Release, 2024
- Infection and transmission of henipavirus in animalsComparative Immunology, Microbiology and Infectious Diseases, 2024
- An Immunoinformatics Prediction of Novel Multi-Epitope Vaccines Candidate Against Surface Antigens of Nipah VirusInternational Journal of Peptide Research and Therapeutics, 2022
- Generating human artery and vein cells from pluripotent stem cells highlights the arterial tropism of Nipah and Hendra virusesCell, 2022
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA VaccinesMolecular Therapy Nucleic Acids, 2019
- Paramyxovirus Entry2013
- The role of apolipoprotein E in the elimination of liposomes from blood by hepatocytes in the mouseBiochemical and Biophysical Research Communications, 2005
- Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccinesCellular and Molecular Life Sciences, 2004
- A Golden Hamster Model for Human Acute Nipah Virus InfectionThe American Journal of Pathology, 2003
- Fatal encephalitis due to Nipah virus among pig-farmers in MalaysiaThe Lancet, 1999